ConductScience.org, home

Paper29130076

CRISPR Correction of a Homozygous Low-Density Lipoprotein Receptor Mutation in Familial Hypercholesterolemia Induced Pluripotent Stem Cells.

Omer L and 5 others. Hepatol Commun, 2017. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. CRISPR Correction of a Homozygous Low-Density Lipoprotein Receptor Mutation in Familial Hypercholesterolemia Induced Pluripotent Stem Cells. Papers, record 29130076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29130076

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CRISPR Correction of a Homozygous Low-Density Lipoprotein Receptor Mutation in Familial Hypercholesterolemia Induced Pluripotent Stem Cells.
PubMed
Journal
Hepatol Commun
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
2.09
iCite
Revised in PubMed
2022-03-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Omer LLinda
2Hudson EAElizabeth A
3Zheng SShirong
4Hoying JBJames B
5Shan YYuan
6Boyd NLNolan L

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R21 EB022185NIBIB NIH HHSUnited StatesR21EB022185PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126009596Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.Eur Heart J2015https://conductscience.org/library/papers/26009596PubMed
227882690The complexities of homozygous familial hypercholesterolemia management.Pediatr Transplant2016https://conductscience.org/library/papers/27882690PubMed
327466105Chinese scientists to pioneer first human CRISPR trial.Nature2016https://conductscience.org/library/papers/27466105PubMed
43472763The LDL receptor in familial hypercholesterolemia: use of human mutations to dissect a membrane protein.Cold Spring Harb Symp Quant Biol1986https://conductscience.org/library/papers/3472763PubMed
523992846Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.Cell2013https://conductscience.org/library/papers/23992846PubMed
622726558Use of indocyanine green for functional assessment of human hepatocytes for transplantation.Asian J Surg2012https://conductscience.org/library/papers/22726558PubMed
725803306Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.Nat Biotechnol2015https://conductscience.org/library/papers/25803306PubMed
827572891Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia.Nat Commun2016https://conductscience.org/library/papers/27572891PubMed
919736565Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.Cell Res2009https://conductscience.org/library/papers/19736565PubMed
1024157548Genome engineering using the CRISPR-Cas9 system.Nat Protoc2013https://conductscience.org/library/papers/24157548PubMed
1128300165Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease.Sci Rep2017https://conductscience.org/library/papers/28300165PubMed
122236051Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2236051PubMed
137584986A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia.Nat Med1995https://conductscience.org/library/papers/7584986PubMed
1415884436Successful transplantation of hepatocytes requires temporary elimination of scavenger and NK cells, partial hepatectomy and ligation of bile duct.Ann Transplant2004https://conductscience.org/library/papers/15884436PubMed
151722351Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.Science1991https://conductscience.org/library/papers/1722351PubMed
1623247991Disease-corrected hepatocyte-like cells from familial hypercholesterolemia-induced pluripotent stem cells.Mol Biotechnol2013https://conductscience.org/library/papers/23247991PubMed
1717380167Mechanisms of disease: genetic causes of familial hypercholesterolemia.Nat Clin Pract Cardiovasc Med2007https://conductscience.org/library/papers/17380167PubMed
1825282520Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial.Lancet2015https://conductscience.org/library/papers/25282520PubMed
192088165The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein.Annu Rev Genet1990https://conductscience.org/library/papers/2088165PubMed
2022653811JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia.Hepatology2012https://conductscience.org/library/papers/22653811PubMed

See all 46 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
41424006Gene Editing of Pluripotent Stem Cell-Derived Hepatic Cells for Liver Disease Modeling and Therapeutic Development.Biomol Ther (Seoul)2026https://conductscience.org/library/papers/41424006PubMed
41096700Application of Induced Pluripotent Stem Cells (iPSCs) in Hereditary and Viral Diseases of the Liver: Modeling and Treatment.Int J Mol Sci2025https://conductscience.org/library/papers/41096700PubMed
40399983Long noncoding RNAs in familial hypercholesterolemia: biomarkers, therapeutics, and AI in precision medicine.Lipids Health Dis2025https://conductscience.org/library/papers/40399983PubMed
40352243Design of lipid nanoparticle (LNP) containing genetic material CRISPR/Cas9 for familial hypercholesterolemia.Narra J2025https://conductscience.org/library/papers/40352243PubMed
39228490Therapeutic Gene Editing in Dyslipidemias.Rev Cardiovasc Med2024https://conductscience.org/library/papers/39228490PubMed
39070027Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond.Am J Prev Cardiol2024https://conductscience.org/library/papers/39070027PubMed
38255763iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.Int J Mol Sci2024https://conductscience.org/library/papers/38255763PubMed
38059350Is It Ever Wise to Edit Wild-Type Alleles? Engineered CRISPR Alleles Versus Millions of Years of Human Evolution.Arterioscler Thromb Vasc Biol2024https://conductscience.org/library/papers/38059350PubMed
37926787Stem cell therapy for hepatocellular carcinoma and end-stage liver disease.J Egypt Natl Canc Inst2023https://conductscience.org/library/papers/37926787PubMed
37545694What did CRISPR-Cas9 accomplish in its first 10 years?Biochem Med (Zagreb)2023https://conductscience.org/library/papers/37545694PubMed
37371118A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD.Cells2023https://conductscience.org/library/papers/37371118PubMed
37017558Nanotechnology-enabled gene delivery for cancer and other genetic diseases.Expert Opin Drug Deliv2023https://conductscience.org/library/papers/37017558PubMed
36980941How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment.Genes (Basel)2023https://conductscience.org/library/papers/36980941PubMed
36725417Gene editing for dyslipidemias: New tools to "cut" lipids.Atherosclerosis2023https://conductscience.org/library/papers/36725417PubMed
36556333CRISPR-Based Tools for Fighting Rare Diseases.Life (Basel)2022https://conductscience.org/library/papers/36556333PubMed
36295590Perioperative Management and Clinical Outcomes of Liver Transplantation for Children with Homozygous Familial Hypercholesterolemia.Medicina (Kaunas)2022https://conductscience.org/library/papers/36295590PubMed
36125710Induction of Bile Canaliculi-Forming Hepatocytes from Human Pluripotent Stem Cells.Methods Mol Biol2022https://conductscience.org/library/papers/36125710PubMed
36044927From a Single Cell to a Whole Human Liver: Disease Modeling and Transplantation.Semin Liver Dis2022https://conductscience.org/library/papers/36044927PubMed
35813199Regulatory Non-Coding RNAs in Familial Hypercholesterolemia, Theranostic Applications.Front Cell Dev Biol2022https://conductscience.org/library/papers/35813199PubMed
35294680Successful induction of human chemically induced liver progenitors with small molecules from damaged liver.J Gastroenterol2022https://conductscience.org/library/papers/35294680PubMed

See all 42 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29130076

GET https://conductscience.org/api/papers/v1/29130076/references?page=2